Stocksigma LogoStocksigma Logo

Tavexia Lifecare Board to Consider Q2 Results, Fund Raising, and RTA Change

Tavexia Lifecare Limited's Board of Directors will meet on 4th Nov'26 to evaluate and approve unaudited standalone and consolidated financial results for

Tavexia Lifecare Board to Consider Q2 Results, Fund Raising, and RTA Change

Sattva Sukun Lifecare Ltd 路 Intimation 路 04 Nov 2026, 5:30 am

Tavexia Lifecare Board to Consider Q2 Results, Fund Raising, and RTA Change Tavexia Lifecare Limited's Board of Directors will meet on 4th Nov'26 to evaluate and approve unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. The board will also discuss a fundraising proposal via the issuance of equity shares or warrants through a preferential issue, rights issue, or other modes. Additionally, it will review the proposed change of its Registrar and Share Transfer Agent (RTA). The insider trading window remains closed until 48 hours post-earnings release.

Original exchange filing (PDF)

More announcements from Sattva Sukun Lifecare Ltd

All Sattva Sukun Lifecare Ltd announcements